101 – 110 of 177
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Crypt cell dosimetry for 99Tcm-sestamibi in a new small intestinal dosimetry model.
(
- Contribution to journal › Article
-
Mark
Biotinylation, pharmacokinetics, and extracorporeal adsorption of humanized MAb 111In-MN14 using an avidin-affinity column in rats.
(
- Contribution to journal › Article
-
Mark
3D absorbed dose calculations based on SPECT: Evaluation for 111-In/90-Y therapy using Monte Carlo simulations.
(
- Contribution to journal › Article
-
Mark
Medical physics e-learning training materials. Information Technology Applications in Biomedicine
2003) 4th Annual IEEE EMBS Special Topic Conf on Information Technology Applications in Biomedicine, ITAB 2003 p.94-97(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2002
-
Mark
Application of extracorporeal immunoadsorption to reduce circulating blood radioactivity after intraperitoneal administration of indium-111-HMFG1-biotin.
(
- Contribution to journal › Article
-
Mark
FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma.
(
- Contribution to journal › Article
-
Mark
A dosimetry model for the small intestine incorporating intestinal wall activity and cross-doses.
(
- Contribution to journal › Article
-
Mark
Time dependence of the activity concentration ratio of red marrow to blood and implications for red marrow dosimetry.
(
- Contribution to journal › Article
-
Mark
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
(
- Contribution to journal › Article
-
Mark
A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation.
(
- Contribution to journal › Article